Skip to main content
Clinical Trials/NCT04108754
NCT04108754
Completed
Not Applicable

Small-vessel Disease Burden and Early Risk of Stroke After Transient Ischemic Attack

Hospices Civils de Lyon1 site in 1 country376 target enrollmentAugust 1, 2018

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Diagnosis of TIA
Sponsor
Hospices Civils de Lyon
Enrollment
376
Locations
1
Primary Endpoint
stroke recurrence within 90 days,
Status
Completed
Last Updated
6 years ago

Overview

Brief Summary

Predicting the risk of stroke remains a challenge in the management of transient ischemic attack (TIA). In addition to clinical variables, morphological features such as the presence of a diffusion weighted sequence (DWI) lesion and carotid stenosis of at least 50% improve risk stratification and are considered in the literature. score ABCD3-I1. Several studies have shown that brain microhemorrhages are associated with the risk of early stroke in patients with TIA. Data on white matter hypersignals on the T2-weighted sequence or FLAIR (FLuid Attenuated Inversion Recovery) are more conflicting. The global microangiopathic load, including the gaps, the hypersignals of the white matter, the perivascular spaces visible on MRI in the basal ganglia, especially when they are very numerous (> 20) and the gaps, have recently been described as being associated with stroke risk within 2 to 3 years of TIA or ischemic stroke. To date, the predictive value of global microangiopathic burden on early stroke risk in the course of TIA is not known.

Registry
clinicaltrials.gov
Start Date
August 1, 2018
End Date
December 1, 2018
Last Updated
6 years ago
Study Type
Observational
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Patients with probable TIA with Regression of symptoms within 24 hours (unilateral motor or sensory disorders affecting the face and / or limbs , language disorder, blindness of an eye or amputation of a visual field)
  • Patients with possible AIT with 2 of these symptoms associated: fear of heights, diplopia, dysarthria, disorders of swallowing, loss of balance, isolated sensory symptoms affecting only part of a limb or hemiface.
  • Patient who have had a brain MRI.
  • Patient over 18 year-old.
  • Patient who give their non opposition to participate at the study.

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

stroke recurrence within 90 days,

Time Frame: 90 days

The stroke recurrence within 90 days is determined via a clinical consultation or telephone call to the patient with a structured questionnaire.

Study Sites (1)

Loading locations...

Similar Trials